ASP Isotopes Inc. Common Stock (ASPI) — Stock Valuation & Research

ASP Isotopes Inc. is an emerging advanced materials company, currently in its pre-commercial stage. This firm is dedicated to the comprehensive management of isotopes, encompassing their creation, dissemination, promotion, and eventual sale. The company's developmental portfolio includes Molybdenum-100, a non-radioactive isotope designed for medical applications, alongside Carbon-14 and Silicon-28. Furthermore, ASP Isotopes is involved with Uranium-235, a specific uranium isotope considered crucial for the carbon-free energy sector. Established in 2021, the company maintains its headquarters…

ASPI key statistics

Price$1.89
Market cap$289.75M
SectorBasic Materials
IndustryChemicals - Specialty
ExchangeNASDAQ
52-week range1.87-9.38
Beta3.78

Explore ASPI's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.